RPG Life Sciences is currently trading at Rs. 155.00, up by 6.10 points or 4.10% from its previous closing of Rs. 148.90 on the BSE.
The scrip opened at Rs. 153.40 and has touched a high and low of Rs. 159.90 and Rs. 153.00 respectively. So far 80706 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 8 has touched a 52 week high of Rs. 159.90 on 27-Mar-2015 and a 52 week low of Rs. 57.50 on 28-Mar-2014.
Last one week high and low of the scrip stood at Rs. 159.90 and Rs. 128.20 respectively. The current market cap of the company is Rs. 257.63 crore.
The promoters holding in the company stood at 61.83% while Institutions and Non-Institutions held 1.81% and 36.37% respectively.
Harsh Vardhan Goneka, trustee of Nucleus Life Trust, bought 277,165 equity shares representing 1.7% of total equity of RPG Life Sciences through open market. Moreover, on March 26, Nucleus Life Trust had purchased 83,376 shares of RPG Life Sciences at an average price of Rs 142.47 per share on the NSE, the bulk deal data shows.
RPG Life Sciences is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organization.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1782.45 |
Dr. Reddys Lab | 1217.75 |
Cipla | 1488.15 |
Lupin | 2064.35 |
Zydus Lifesciences | 947.50 |
View more.. |